Dysplasia in ulcerative colitis as a predictor of unsuspected synchronous colorectal cancer

Diseases of the Colon and Rectum

Volumn 57, Issue 8, 2014, Pages 993-998

  Murphy, Jamie ^a   Kalkbrenner, Kristen A ^a   Pemberton, John H ^b   Landmann, Ron G ^c   Heppell, Jacques P ^a   Young Fadok, Tonia M ^a   Etzioni, David A ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Cancer; Colectomy; Dysplasia; Ulcerative colitis

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE DURATION; DYSPLASIA; FAMILY HISTORY; FEMALE; HUMAN; ILEOSTOMY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PANCOLITIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIMARY SCLEROSING CHOLANGITIS; PROCTOCOLECTOMY; RETROSPECTIVE STUDY; TOTAL COLON RESECTION; ULCERATIVE COLITIS;

AGED; BIOPSY; CELL TRANSFORMATION, NEOPLASTIC; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES;

EID: 84904906733     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0000000000000172     Document Type: Article

References (27)

1. Efthymiou M, Taylor AC, Kamm MA. Cancer surveillance strategies in ulcerative colitis: the need for modernization. Inflamm Bowel Dis. 2011;17: 1800-1813.
2. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323: 1228-1233. (Pubitemid 20366527)
3. Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91: 854-862. (Pubitemid 32173312)
4. van Schaik FD, Offerhaus GJ, Schipper ME, Siersema PD, Vleggaar FP, Oldenburg B. Endoscopic and pathological aspects of colitis-associated dysplasia. Nat Rev Gastroenterol Hepatol. 2009;6: 671-678.
5. Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138: 746-74, 774.e1.
6. Farraye FA, Odze RD, Eaden J, et al; AGA Institute Medical Position Panel on Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138: 738-745.
7. Thomas T, Abrams KA, Robinson RJ, Mayberry JF. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther. 2007;25: 657-668.
8. Zisman TL, Bronner MP, Rulyak S, et al. Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines. Inflamm Bowel Dis. 2012;18: 2240-2246.
9. van Schaik FD, ten Kate FJ, Offerhaus GJ, et al; Dutch Initiative on Crohn and Colitis. Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia. Inflamm Bowel Dis. 2011;17: 1108-1116.
10. Rozen P, Baratz M, Fefer F, Gilat T. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology. 1995;108: 1361-1370.
11. Woolrich AJ, DaSilva MD, Korelitz BI. Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology. 1992;103: 431-438.
12. Jess T, Loftus EV Jr, Velayos FS, et al. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Inflamm Bowel Dis. 2006;12: 669-676. (Pubitemid 44253749)
13. Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130: 1030-1038.
14. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet. 1994;343: 71-74. (Pubitemid 24019346)
15. Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz S. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology. 2003;125: 1311-1319. (Pubitemid 37409751)
16. Lennard-Jones JE, Morson BC, Ritchie JK, Shove DC, Williams CB. Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology. 1977;73: 1280-1289. (Pubitemid 8229277)
17. Fuson JA, Farmer RG, Hawk A, Sullivan BH. Endoscopic surveillance for cancer in chronic ulcerative colitis. Am J Gastroenterol. 1980;73: 120-126. (Pubitemid 10083209)
18. Kewenter J, Hultén L, Ahrén C. The occurrence of severe epithelial dysplasia and its bearing on treatment of longstanding ulcerative colitis. Ann Surg. 1982;195: 209-213. (Pubitemid 12222885)
19. Rosenstock E, Farmer RG, Petras R, Sivak MV Jr, Rankin GB, Sullivan BH. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology. 1985;89: 1342-1346. (Pubitemid 16228058)
20. von Herbay A, Herfarth C, Otto HF. Cancer and dysplasia in ulcerative colitis: a histologic study of 301 surgical specimen. Z Gastroenterol. 1994;32: 382-388. (Pubitemid 24261772)
21. Nugent FW, Haggitt RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology. 1991;100(5 pt 1): 1241-1248.
22. Connell WR, Talbot IC, Harpaz N, et al. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut. 1994;35: 1419-1423. (Pubitemid 24310904)
23. Taylor BA, Pemberton JH, Carpenter HA, et al. Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis Colon Rectum. 1992;35: 950-956.
24. Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology. 1994;107: 117-120. (Pubitemid 24195353)
25. Bernstein CN, Blanchard JF, Metge C, Yogendran M. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am J Gastroenterol. 2003;98: 2784-2788. (Pubitemid 38020124)
26. Velayos FS, Terdiman JP, Walsh JM. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and meta-analysis of observational studies. Am J Gastroenterol. 2005;100: 1345-1353. (Pubitemid 40904360)
27. Cairns SR, Scholefield JH, Steele RJ, et al; British Society of Gastroenterology; Association of Coloproctology for Great Britain and Ireland. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59: 666-689.